Quantitative Systematic Strategies LLC acquired a new stake in shares of Constellium (NYSE:CSTM) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 12,525 shares of the industrial products company’s stock, valued at approximately $136,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. California Public Employees Retirement System raised its holdings in shares of Constellium by 0.7% during the fourth quarter. California Public Employees Retirement System now owns 727,100 shares of the industrial products company’s stock valued at $8,107,000 after purchasing an additional 4,700 shares during the last quarter. HBK Investments L P grew its position in Constellium by 1.7% during the fourth quarter. HBK Investments L P now owns 449,658 shares of the industrial products company’s stock valued at $5,014,000 after buying an additional 7,658 shares during the period. Essex Investment Management Co. LLC bought a new stake in Constellium during the fourth quarter valued at approximately $115,000. Bank of New York Mellon Corp bought a new stake in Constellium during the fourth quarter valued at approximately $147,000. Finally, Wells Fargo & Company MN grew its position in Constellium by 3.5% during the fourth quarter. Wells Fargo & Company MN now owns 423,875 shares of the industrial products company’s stock valued at $4,726,000 after buying an additional 14,392 shares during the period. 82.04% of the stock is owned by hedge funds and other institutional investors.
Shares of Constellium opened at $12.60 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 0.68, a current ratio of 1.23 and a debt-to-equity ratio of -6.23. Constellium has a fifty-two week low of $6.20 and a fifty-two week high of $14.10.
Constellium (NYSE:CSTM) last issued its earnings results on Thursday, April 26th. The industrial products company reported ($0.18) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.35). Constellium had a negative return on equity of 5.81% and a negative net margin of 1.33%. The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the company posted $0.12 EPS. Constellium’s revenue was up 4.4% compared to the same quarter last year. research analysts forecast that Constellium will post 1.02 EPS for the current year.
Several brokerages recently issued reports on CSTM. ValuEngine upgraded shares of Constellium from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. BMO Capital Markets upped their price target on shares of Constellium from $13.00 to $14.00 and gave the stock a “market perform” rating in a research report on Friday, April 27th. Seaport Global Securities upgraded shares of Constellium from a “neutral” rating to a “buy” rating and upped their price target for the stock from $14.00 to $16.00 in a research report on Friday, April 27th. Societe Generale lowered shares of Constellium from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. Finally, Goldman Sachs initiated coverage on shares of Constellium in a research report on Tuesday, March 20th. They issued a “buy” rating and a $16.00 price target for the company. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $16.20.
Constellium N.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive end-markets. The company operates in three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium (NYSE:CSTM).
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.